iiinova — where your digital self keeps evolving

Maurizio Callari @mauriziocallari.bsky.social · 24/11/2025

Another great paper from @caldaslab.bsky.social! TME composition evaluated in 15k breast cancer transcriptomes!

Reposted by Maurizio Callari

Fondazione Gianni Bonadonna @fgbonadonna.bsky.social · 10/11/2025

mRNA vaccines targeting non-tumor-related antigens are potent immune modulators capable of sensitizing tumors to immune checkpoint blockade fondazionebonadonna.org/en/sars-cov-... #FondazioneBonadonna #Oncology #CancerResearch @mauriziocallari.bsky.social

fondazionebonadonna.org

SARS-CoV-2 vaccines sensitize tumors to immune checkpoint blockade

Fondazione Gianni Bonadonna

021

Maurizio Callari @mauriziocallari.bsky.social · 18/06/2025

Having a great time at #EACR2025, catching up and continuing doing exciting science with @carloscaldas1960.bsky.social and @caldaslab.bsky.social!

051

Reposted by Maurizio Callari

Fondazione Gianni Bonadonna @fgbonadonna.bsky.social · 19/05/2025

Afami-cel showed durable responses in heavily pretreated patients with sarcoma, providing a rationale for the treatment of solid tumors with a T-cell receptor therapy fondazionebonadonna.org/en/afamitres... #fondazionebonadonna #oncology #CancerResearch @mauriziocallari.bsky.social

fondazionebonadonna.org

Afamitresgene autoleucel in advanced synovial sarcoma and myxoid round cell liposarcoma

Fondazione Gianni Bonadonna

011

Reposted by Maurizio Callari

Long V. Nguyen @nguyenlab.bsky.social · 12/05/2025

I am excited to share the latest publication from the Nguyen, Caldas @carloscaldas1960.bsky.social and Rueda labs @ruedalab.bsky.social. This was a massive effort from a fantastic team and I’m grateful to everyone on the paper for their work on this project! doi.org/10.1016/j.ce... #bcsm #PDTX

doi.org

Redirecting

3146

Reposted by Maurizio Callari

Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 16/04/2025

1/n Fantastic to see this published. Anticipatory genomics demonstration: ctDNA and ML to predict CT progression! Well done @emmajb001.bsky.social and @mortegaduran.bsky.social! Great collaboration of @caldaslab.bsky.social with @ruedalab.bsky.social! #DETECT started by @sj-dawson.bsky.social!

165

Maurizio Callari @mauriziocallari.bsky.social · 10/03/2025

Here an overview of our #translational research on samples from the #NAPHER2 trial recently published in #NatComms @natureportfolio.nature.com. We identified #predictive #biomarkers and molecular dynamics in HER2+ER+ #breastcancer receiving chemo-free #targeted #treatment 👇

020

Reposted by Maurizio Callari

Fondazione Gianni Bonadonna @fgbonadonna.bsky.social · 03/03/2025

Nivolumab plus ipilimumab show superior progression-free survival versus nivolumab in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer fondazionebonadonna.org/en/nivolumab... #fondazionebonadonna #oncology #CancerResearch @mauriziocallari.bsky.social

fondazionebonadonna.org

Nivolumab and ipilimumab in metastatic colorectal cancer

Fondazione Gianni Bonadonna

021

Reposted by Maurizio Callari

EACR - European Association for Cancer Research @helloeacr.bsky.social · 19/02/2025

Listen to episode 19 of The Cancer Researcher Podcast where @carloscaldas1960.bsky.social shares insights into his breast cancer research, the evolution of cancer science & the power of patient-derived xenograft models ahead of his Keynote Talk at EACR 2025. magazine.eacr.org/insights-fro...

magazine.eacr.org

Insights from a Keynote Speaker: Episode 19 of The Cancer Researcher Podcast - The Cancer Researcher

Carlos Caldas shares insights into his breast cancer research and the power of patient-derived xenograft models.

051

Reposted by Maurizio Callari

Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 06/02/2025

Just finished a Teams meeting with @mauriziocallari.bsky.social and Oscar Rueda discussing Single Nucleus Sequencing generated by @sc10021.bsky.social from 150 #METABRIC breast cancers, in conjunction with all the other multi-omic data. At #EACR2025 update coming...

062

Maurizio Callari @mauriziocallari.bsky.social · 29/11/2024

Amazing resource for pre-clinical research in triple-negative breast cancer!

031

Reposted by Maurizio Callari

Nuria Lopez-Bigas @nlbigas.bsky.social · 25/11/2024

We recently announced a dual new release of intOGen and boostDM Computational analysis of 33,218 tumor genomes to identify cancer genes and driver mutations ➡️ Compendium of Cancer Driver Genes - www.intogen.org ➡️ In Silico Saturation Mutagenesis of Cancer Genes - www.intogen.org/boostdm

08333

Maurizio Callari @mauriziocallari.bsky.social · 21/11/2024

A great piece of work, I'm happy to have contributed to during my time in Cambridge! #PDX #breastcancer #drug #response #prediction

010

Reposted by Maurizio Callari

Itai Yanai @itaiyanai.bsky.social · 20/11/2024

Out today in Nature: "The Human Cell Atlas"! In my News and Views, I compare the cell atlas to early naturalists creating an atlas of South America. Researchers mining this cell atlas can now make big discoveries, just as the next naturalists then discovered evolution. www.nature.com/articles/d41...

321662